SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ekso Bionics Holdings, Inc. engages in the provision of design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.

Ekso Bionics Holdings Inc

Ekso Bionics is experiencing extreme volatility and massive trading volume following news of a proposed merger with Applied Digital's cloud computing business to form the AI-focused ChronoScale platform. The community is highly divided, with many anticipating a significant short squeeze and parabolic move fueled by AI enthusiasm, while others express strong concerns about potential massive dilution for existing EKSO shareholders.

🔥 COCK Token – The Ultimate Cross-Chain MemeFi Powerhouse 🔥  In just under 20 days, $COCK has smashed expectations, broken ATHs, and built a project that’s shaking up Cardano and the entire crypto space. 🐓 What Makes $COCK Special?      The Name: Love it or hate it, the energy and engagement it generates are undeniable. The nuance in language and wild appeal set us apart.     #MEMEFI Pioneer: We’re not just another meme coin. $COCK is leading a movement by combining DeFi mechanics, game theory, and community engagement into a groundbreaking ecosystem.     COCKARENA: At the core of our ecosystem is the COCKARENA, a PvP HODL game. Players battle it out, and early exit fees fuel redistributions, burns, and the treasury. This ensures price appreciation and long-term sustainability for loyal holders.  🎰 The COCK Casino  Our casino isn’t just fun—it’s a serious revenue stream for the FLOCK.      Games: Bonanza, Crash, Blackjack, and Roulette (coming soon!).     Impact: Over 7,834 ADA in profits generated within days, directly supporting rewards, burns, and reinvestment.  💰 COCK-ARENA Loans  Unlock liquidity without selling your tokens.      Loan Terms: Borrow up to 30% of your holdings while continuing to earn rewards in the arena.     Investor Focus: Perfect for savvy investors staying in the game while tapping into their holdings.  🤝 Our Insane Partnerships  We’re bridging gaps, building alliances, and breaking barriers across the crypto space. Key Partners:      DANZO: Powering #MEMEFI with Arena, Casino, and Loans.     KLENEK: Interactive training room.     HSKN (Charles Hoskilien): Supporting and starting COCKPIN with 115 AIR NODES for DePIN aggregation. Plans to add APEX and Earth Nodes through a crypto company incorporated in Costa Rica.     ELITE CATS / SNEKKIES / HOT / BANK: Rewarding NFT holders with COCK-LOCK tokens and vice versa.     OCKZ: COCKSOCKS, Golden Cock Ticket (1M COCK), airdrop rewards, and whitelist perks for holders of 200 ADA worth of $COCK.     OLI Partnership:         Content Creation: Lux and the team are crafting engaging educational content about memes and MemeFi for OLi's platform.         Strategic Investment: The OLi Community Trust will invest in $COCK, distributing 100% of rewards to $OLI holders.         Community Reach: Over 22,000 learners will discover $COCK through OLi's gamified ecosystem.     Hi-Rez the Rapper: Expanding reach in marketing and entertainment.     KUNO, CALEB, CADEN, FITY, ROVER, WhaleInsider: Influential collaborators driving crypto adoption and growth.     Cardano Girls: Helping us understand and communicate effectively with ADA’s female audience.     WallStreetBets: Breaking barriers and increasing engagement.     Antonio Brown: Endorsing, supporting, and even playing in the casino and arena!     Advisors:         BERIS, HECKTHESNEK, RTB, CRYPTOGENIUS: Trusted names advising and supporting the project.  Future Partnerships:  More collaborations are in the pipeline to continue expanding engagement and bring new eyes to ADA and CNTs. 🔥 Unmatched Results in Just 20 Days      Supply Burned: 1.65%, worth 148K ADA!     Arena Fees Collected: 54M COCK, worth over 500K ADA, fueling rewards, burns, and partnerships.     Staked COCK-LOCK: 11M COCK-LOCK in the liquid staking platform, with more coming.     Casino Revenue: Skyrocketing profits directly rewarding holders and growing the treasury.     Top Blast Contests: Generated over 120K ADA in volume, rewarding participants with over 50K ADA in prizes.  🌍 Our Vision  To be the most decentralized, rewarding, and innovative token on Cardano while fostering cross-chain collaboration and onboarding the masses.      Breaking Barriers: We’re bringing BTC, ETH, SOL, and other chains into the fold.     Community-Driven: Focused on building bridges and showcasing that crypto can be fun, rewarding, and sustainable.     Expansion: This is just the beginning. With more burns, rewards, and partnerships on the way, $COCK is set to redefine what’s possible in the MemeFi space.  💎 Time in the arena > Timing the market. The FLOCK is unstoppable. Let’s keep breaking walls for Cardano and onboard new users as we take $COCK to new heights.

CockCardano

COCK CRYPTO is generating significant buzz, driven by its innovative real-world asset integration through CockyWings LLC, which fuels token buybacks and brings external revenue on-chain. The community is actively celebrating this utility and the recent launch of its new MemesHub.io DApp, solidifying its position as a key player within the Cardano ecosystem.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is experiencing significant activity as the market anticipates a crucial Department of Energy announcement regarding surplus plutonium awards, expected by year-end, which could be a major catalyst for its advanced nuclear technology. Bulls point to heavy institutional buying, massive call option activity, and high short interest creating squeeze potential, while bears express strong concerns over extreme valuation, ongoing share dilution, and recent insider selling. This creates a highly contested landscape as investors weigh Oklo's role in future energy solutions for sectors like AI.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust is experiencing extreme volatility and trending due to immediate anticipation of Chinese export restrictions on silver, effective January 1st, coupled with strong industrial demand from the AI and EV sectors. The community is fiercely debating whether recent price drops, attributed to increased CME margin requirements, are manipulative tactics or merely a shakeout of leveraged positions before a potential short squeeze. This has intensified discussions around the significant divergence between physical silver's scarcity and its paper market price, with many anticipating substantial new highs for the metal.

BUUU Group Ltd. is a holding company, which operates through its subsidiaries, BU Creation and BU Workshop. Its subsidiaries engage in design, planning and production of face-to-face events, immersive environments and brand-based experiences for clients and venues, including event organizers, consumer brand marketers and retail shopping centers. The company was founded in 2017 and is headquartered in Hong Kong.

BUUU Group Ltd. - Ordinary Shares - Class A

BUUU Group Ltd

BUUU is experiencing significant, volatile price movements and trading halts, landing it on top gainers lists. The community is sharply divided between those anticipating rapid gains and others warning of a messaging app-driven "pump and dump" scheme for this recent Hong Kong-based IPO. Many traders are also discussing issues with order execution, contributing to the intense conversation around its swift swings on light volume.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is trending due to the impressive Phase 3 trial data for relacorilant in platinum-resistant ovarian cancer, which sparked a significant rally and subsequent volatility. The community is actively debating a potential short squeeze on upcoming FDA decisions for its Cushing Syndrome treatment and ovarian cancer indication, alongside discussions about recent earnings performance and a distribution partner change. Enthusiasm for its diverse pipeline, including promising ALS survival data, is countered by caution over the stock's sharp price fluctuations.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

Rocket Companies is actively trending as the community anticipates a significant mortgage refinancing wave, fueled by improving home purchase applications and broader housing market recovery. Investors are highlighting the company's integrated platform, AI-driven efficiencies, and robust institutional accumulation as key factors driving a potential re-rating in the evolving real estate sector.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

Ultragenyx Pharmaceutical is trending following a significant setback as its lead setrusumab Phase 3 trials for osteogenesis imperfecta failed to meet primary endpoints for fracture reduction. This news has triggered sharp analyst price target cuts and a valuation reset, though many in the community view the immediate selloff as an overreaction. Discussions are now focused on the company's robust pipeline and other approved therapies, which some believe present a compelling buying opportunity amid the broader re-evaluation of its future growth strategy.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI (SOUN) is currently trending with high anticipation for potential new partnerships and announcements at the upcoming Consumer Electronics Show (CES) in early January. Sentiment is mixed, with many investors highlighting recent analyst upgrades and strong fundamentals as reasons to expect a significant rebound, viewing the stock as oversold. However, others express frustration over its substantial price decline and past volatility, questioning its immediate trajectory despite its position in the voice AI market.

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Verastem (VSTM) is trending after announcing its decision to discontinue the RAMP 203 trial for KRAS G12C lung cancer, aiming to prioritize the promising VS-7375 program, an oral KRAS G12D inhibitor. While some investors view this as a strategic move to focus on a high-efficacy asset in a less crowded market, the community is actively debating the timing and transparency of management's communication. This strategic shift and a recent dilutive offering have fueled discussions around perceived stock manipulation by shorts and the company's valuation despite its long-term potential in advanced oncology.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


hot51apktv2026

Hot51apk Tv